For Release: Immediately For more information contact:
Joan Schuman/Joan Schuman Assoc
845.338.2955/jsa@hvc.rr.com

Kingston, NY—April 2007. River Radiology in Kingston NY expanded its health and wellness services available to patients with the addition of a new digital mammography system. “The Selenia digital mammography provides our patients the highest quality of care in the early detection of breast cancer,” said Susan Connors, Medical Director of River Radiology.

Digital mammography allows the radiologic technologists to view the x-ray image more closely zeroing in on suspicious or concerning areas, enabling them to make immediate decisions about additional images. Digital mammography also takes less than half the time of traditional film-based exams.

According to Connors, “We can view and manipulate the images on high-resolution computer monitors that enhance visualization of the structures within the breast tissue. We can also adjust brightness and contrast, and zoom in on specific areas to help detect small calcifications, masses, and other changes that may be signs of early cancer. Our goal is to provide the best possible care to our patients, and this advanced digital technology helps us do that.”

“For most women with some history of breast cancer, annual mammography is insufficient,” said Dr. Susan Connors. “These women need more comprehensive and sensitive imaging and that’s why we offer a full complement of breast imaging technologies at River Radiology.” The new technology includes GE VIBRANT MRI which allows simultaneous MRI imaging of both breasts; DynaCad 3D digital imaging which dramatically improves the ability to detect breast cancer; and advanced, new Phillips breast ultrasound equipment.

Breast cancer is the second leading cause of cancer death among women, exceeded only by lung cancer. Statistics from the American Cancer society demonstrate that one in eight women will develop breast cancer sometime in her life. The stage at which breast cancer is detected influences a woman’s survival. If detected early, the five-year survival rate is now 97%.